Pieris Pharmaceuticals
PIRS
#9791
Rank
ยฃ14.13 M
Marketcap
ยฃ10.71
Share price
-15.58%
Change (1 day)
8.73%
Change (1 year)

Revenue for Pieris Pharmaceuticals (PIRS)

Revenue in 2024 (TTM): ยฃ16.04 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ15.41 Million. In 2022 the company made a revenue of ยฃ21.41 Million a decrease over the revenue in the year 2021 that were of ยฃ23.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pieris Pharmaceuticals from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ16.04 M
2022 ยฃ21.41 M-8.01%
2021 ยฃ23.27 M8.19%
2020 ยฃ21.51 M-39.04%
2019 ยฃ35.29 M53.94%
2018 ยฃ22.92 M22.59%
2017 ยฃ18.7 M295.79%
2016 ยฃ4.72 M174.19%
2015 ยฃ1.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ79.04 M 412.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.97 M-67.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.27 B 144,476.71%๐Ÿ‡บ๐Ÿ‡ธ USA